Roche (RHHBY) announced the CE certification of the new cobas 6800/8800 systems 2.0. The update significantly enhances the efficiency of laboratories by optimizing resources, reducing downtime, consolidating test menus, and increasing throughput. These improvements promise a more streamlined diagnostics experience for healthcare professionals and their patients. Laboratories can now perform a wider range of tests on a single solution, simplifying laboratory logistics and helping to optimize the use of resources.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RHHBY:
- Roche Vabysmo PFS approved in EU for three retinal conditions
- Genentech presents updated fixed-duration Columvi and Lunsumio data at ASH
- Roche commences tender offer for outstanding Poseida shares at $9 per share
- Roche says five-year results confirm Polivy combo as ‘new standard of care’
- Genentech announces FDA acceptance of Columvi combination sBLA